메뉴 건너뛰기




Volumn 60, Issue SUPPL. 12, 1999, Pages 22-23

A historical perspective of clozapine

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; NEUROLEPTIC AGENT;

EID: 0033045962     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (139)

References (24)
  • 1
    • 0023812652 scopus 로고
    • Clozapire for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
    • Kane J, Honigfeld G, Singer J, et al, and the Clozaril Collaborative Study Group. Clozapire for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796
    • (1988) Arch Gen Psychiatry , vol.45 , pp. 789-796
    • Kane, J.1    Honigfeld, G.2    Singer, J.3
  • 3
    • 0013962408 scopus 로고
    • Das Wirkungsprofil eines chemische neuartigen Breitbandneuroleptikums der Dibenzodiazepingruppe
    • Gross H, Langner E. Das Wirkungsprofil eines chemische neuartigen Breitbandneuroleptikums der Dibenzodiazepingruppe. Wien Med Wochenschr 1969;116:814-816
    • (1969) Wien Med Wochenschr , vol.116 , pp. 814-816
    • Gross, H.1    Langner, E.2
  • 4
    • 0009048853 scopus 로고
    • Das klinische Wirkungsspektrum eines neuen Dibenzodiazepin-Derivats
    • Berzewski H, Helmchen H, Hippius H, et al. Das klinische Wirkungsspektrum eines neuen Dibenzodiazepin-Derivats. Arzneimittelforschung 1969;19: 495-496
    • (1969) Arzneimittelforschung , vol.19 , pp. 495-496
    • Berzewski, H.1    Helmchen, H.2    Hippius, H.3
  • 5
    • 0002447720 scopus 로고
    • Das klinische Wirkungsbild von Clozapin
    • Angst J, Bente D, Berner P, et al. Das klinische Wirkungsbild von Clozapin. Pharmakopsychiatrie 1971;4:201-211
    • (1971) Pharmakopsychiatrie , vol.4 , pp. 201-211
    • Angst, J.1    Bente, D.2    Berner, P.3
  • 6
    • 0002447718 scopus 로고
    • Ergebnisse eines Doppelblindversuchs von HF1854 im Vergleich zu Levomepromazin
    • Angst J, Jaenicke U, Padrutt A, et al. Ergebnisse eines Doppelblindversuchs von HF1854 im Vergleich zu Levomepromazin. Pharmakopsychiatrie 1971;4:192-200
    • (1971) Pharmakopsychiatrie , vol.4 , pp. 192-200
    • Angst, J.1    Jaenicke, U.2    Padrutt, A.3
  • 7
    • 0001427177 scopus 로고
    • Kritische Stellungnahme zum Begriff der Neuroleptika (anhand von pharmakologischen und klinischen Befunden mit Clozapin)
    • Stille G, Hippius H. Kritische Stellungnahme zum Begriff der Neuroleptika (anhand von pharmakologischen und klinischen Befunden mit Clozapin). Pharmakopsychiatrie 1971;4:182-191
    • (1971) Pharmakopsychiatrie , vol.4 , pp. 182-191
    • Stille, G.1    Hippius, H.2
  • 8
    • 0017658058 scopus 로고
    • Agranulocytosis in patients treated with clozapine: A study of the Finnish epidemic
    • Amsler HA, Teerenhovi L, Barth E, et al. Agranulocytosis in patients treated with clozapine: a study of the Finnish epidemic. Acta Psychiatr Scand 1977;56:241-248
    • (1977) Acta Psychiatr Scand , vol.56 , pp. 241-248
    • Amsler, H.A.1    Teerenhovi, L.2    Barth, E.3
  • 9
    • 0018565672 scopus 로고
    • Clozapine, chlorpromazine, and placebo in newly hospitalized acutely schizophrenic patients: A controlled, double-blind comparison
    • Shopsin B, Klein H, Aaronsom M, et al. Clozapine, chlorpromazine, and placebo in newly hospitalized acutely schizophrenic patients: a controlled, double-blind comparison. Arch Gen Psychiatry 1979;36:657-664
    • (1979) Arch Gen Psychiatry , vol.36 , pp. 657-664
    • Shopsin, B.1    Klein, H.2    Aaronsom, M.3
  • 11
    • 0026772116 scopus 로고
    • Clinical and biologic response to clozapine in patients with schizophrenia: Crossover comparison with fluphenazine
    • Pickar D, Owen RR, Litman RE, et al. Clinical and biologic response to clozapine in patients with schizophrenia: crossover comparison with fluphenazine. Arch Gen Psychiatry 1992;49:345-353
    • (1992) Arch Gen Psychiatry , vol.49 , pp. 345-353
    • Pickar, D.1    Owen, R.R.2    Litman, R.E.3
  • 12
    • 0028355999 scopus 로고
    • Clozapine effects on positive and negative symptoms: A six-month trial in treatment-refractory schizophrenics
    • Lindenmayer JP, Grochowski S, Mabugat L. Clozapine effects on positive and negative symptoms: a six-month trial in treatment-refractory schizophrenics. J Clin Psychopharmacol 1994;14:201-204
    • (1994) J Clin Psychopharmacol , vol.14 , pp. 201-204
    • Lindenmayer, J.P.1    Grochowski, S.2    Mabugat, L.3
  • 13
    • 0000052449 scopus 로고    scopus 로고
    • Efficacy of elozapine versus haloperidol in a long-term clinical trial
    • Kane JM, Schooler NR, Marder S, et al. Efficacy of elozapine versus haloperidol in a long-term clinical trial [abstract]. Schizophr Res 1996;18:127
    • (1996) Schizophr Res , vol.18 , pp. 127
    • Kane, J.M.1    Schooler, N.R.2    Marder, S.3
  • 14
    • 0031936086 scopus 로고    scopus 로고
    • The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics
    • Miller CH, Mohr F, Umbricht D, et al. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics. J Clin Psychiatry 1998;59:69-75
    • (1998) J Clin Psychiatry , vol.59 , pp. 69-75
    • Miller, C.H.1    Mohr, F.2    Umbricht, D.3
  • 15
    • 0028019245 scopus 로고
    • Effects of clozapine on cognitive function in schizophrenia
    • Lee MA, Thompson PA, Meltzer HY. Effects of clozapine on cognitive function in schizophrenia. J Clin Psychiatry 1994;55(9, suppl B):82-87
    • (1994) J Clin Psychiatry , vol.55 , Issue.9 SUPPL. B , pp. 82-87
    • Lee, M.A.1    Thompson, P.A.2    Meltzer, H.Y.3
  • 16
    • 0024468417 scopus 로고
    • Clinical studies on the mechanism of action of clozapine: The dopamine-serotonin hypotheses of schizophrenia
    • Berl
    • Meltzer HY. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypotheses of schizophrenia. Psychopharmacology (Berl) 1989;99:S18-S27
    • (1989) Psychopharmacology , vol.99
    • Meltzer, H.Y.1
  • 17
    • 0024989576 scopus 로고
    • Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients
    • Meltzer HY, Burnett S, Bastani B, et al. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry 1990;41:892-897
    • (1990) Hosp Community Psychiatry , vol.41 , pp. 892-897
    • Meltzer, H.Y.1    Burnett, S.2    Bastani, B.3
  • 18
    • 0028869668 scopus 로고
    • Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: Impact on risk-benefit assessment
    • Meltzer HY, Okayli G. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry 1995;152:183-190
    • (1995) Am J Psychiatry , vol.152 , pp. 183-190
    • Meltzer, H.Y.1    Okayli, G.2
  • 19
    • 0030778896 scopus 로고    scopus 로고
    • Mortality in current and former users of clozapine
    • Walker AM, Lanza LL, Arellano F, et al. Mortality in current and former users of clozapine. Epidemiology 1997;8:671-677
    • (1997) Epidemiology , vol.8 , pp. 671-677
    • Walker, A.M.1    Lanza, L.L.2    Arellano, F.3
  • 20
    • 0031967082 scopus 로고    scopus 로고
    • Suicide in schizophrenia: Risk factors and clozapine treatment
    • Meltzer HY. Suicide in schizophrenia: risk factors and clozapine treatment. J Clin Psychiatry 1998;59(suppl 3):15-20
    • (1998) J Clin Psychiatry , vol.59 , Issue.3 SUPPL. , pp. 15-20
    • Meltzer, H.Y.1
  • 21
    • 0029584660 scopus 로고
    • Violence and schizophrenia: Clozapine as a specific antiaggressive agent
    • Buckley P, Bartell J, Donenwirth K, et al. Violence and schizophrenia: clozapine as a specific antiaggressive agent. Bull Am Acad Psychiatry Law 1995;23:607-611
    • (1995) Bull Am Acad Psychiatry Law , vol.23 , pp. 607-611
    • Buckley, P.1    Bartell, J.2    Donenwirth, K.3
  • 22
    • 0031956951 scopus 로고    scopus 로고
    • Clozapine reduces violence and persistent aggression in schizophrenia
    • Glazer WM, Dickson RA. Clozapine reduces violence and persistent aggression in schizophrenia. J Clin Psychiatry 1998;59 (suppl 3):8-14
    • (1998) J Clin Psychiatry , vol.59 , Issue.3 SUPPL. , pp. 8-14
    • Glazer, W.M.1    Dickson, R.A.2
  • 23
    • 0026517979 scopus 로고
    • Dimensions of outcome with clozapine
    • Meltzer HY. Dimensions of outcome with clozapine. Br J Psychiatry 1992:160(suppl 17):46-53
    • (1992) Br J Psychiatry , vol.160 , Issue.17 SUPPL. , pp. 46-53
    • Meltzer, H.Y.1
  • 24
    • 0032978563 scopus 로고    scopus 로고
    • Clozapine: The commitment to patient safety
    • Alphs LD, Anand R. Clozapine: the commitment to patient safety. J Clin Psychiatry 1999;60(suppl 12):39-42
    • (1999) J Clin Psychiatry , vol.60 , Issue.12 SUPPL. , pp. 39-42
    • Alphs, L.D.1    Anand, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.